FDA Investigator Lillie M Young

Lillie M Young has inspections in 1 countries as of 22 Sep 2023. Lillie M Young has collaborated with a combinined 1865 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
204
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100006976
Country:
United States of America
Co-Investigator(s):
A Ble Bevill, Adrian Rodriguez, Albert F Peacock, PhD, Amy A Johnson, Andrea A Branche, Anya D Lockett Evans, Ashley N Williams, Blondell W Johnson, Bobbi J Miller, Brackens Harris, Brenda G Stewart Munoz, Carol A Declouette Wilburn, Carol F Robinson, Carolyn A Pinney, Chengru Zhu, Christopher J Hurst, Cody D Rickman, Constance M Dobbins, Cordelia J Brammer, Daniel Pst Laurent, Daphne A Videau, Darla J Christopher, Dawn P Hall, Decarlos A Gomez, Deniza Karacic, Ed Gonzalez Vazquez, Elizabeth D Connell, Elizabeth L Geesaman, Elkins, Ellen J Kleintop, Ellen J Tave, Elmina E Akwo, Elvia J Cervantes, Emily B Camire, Emily S Mcgann, Erma Zaimova, Ernest Serna, III, Everard A Irish, Fernando C Martinez, Frans E Mercado, Frederic W French, III, Gloria A Milster, Grant, Habacuc V Barrera, Hung V Le, Iris C Macinnes, Janice M Hickok, Jennifer A Kemp, Jennifer D Young, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, John D Mays, Julia D Cartwright, Karen J Bak, Kari M Johansen, Kathleen B Swat, Kelly D Moore, Kelly D Sheppard, Kip J Hanks, Laressa R Gray, Latorie S Jones, Lauren E Skokan, Laverne Puckett, Leighton K Ngai, Lesley Maep Lutao, Lillie M Johnson, Lisa M Puttonen, Lisa R Jennings, Lorie S Hannappel, Maira P Brading, Marc A Jackson, Jr, Marion W Nadeau, Mark C Flotte, Martin K Yau, PhD, Melisa A Healy, Merelynn Rhoten, Monica Y Yu, Monique Rac Lester, Mpris Inspector, Nikisha M Bolden, Patricia M Jacobs, Patrick D Stone, MS, Paula J Perry, Ramon L Gonzalez Prieto, Richard T Riggie, Robert M Tillman, Rodriguez, Ronda R Loyd, Ronda R Loyd Jones, Scott T Ballard, Sean W Linder, Staci G Mcallister, State Agency, Steven L Strom, Stuart W Russell, Sunitha K Rajaram, PhD, Theressa B Smith, Toby Vern H Hill, Tracy J Washington, Travis R Hunt, Travis S Bradley, Tricia S Martinez, Tricia Y Santiago, Virginia Ramos, Young M Yoon, Zerita White

Lillie M Young's Documents

Publish Date Document Type Title
March, 2002 EIR Human Investigations Committee of Houston Texas - EIR, 2002-03-25
May, 2002 FDA 483 University of Texas Medical Branch (UTMB) Blood Center - Form 483, 2002-05-20
July, 2003 FDA 483 Biomat USA, Inc. - Form 483, 2003-07-30
June, 2002 EIR Biomat USA, Inc. - EIR, 2002-06-21
June, 2002 FDA 483 University of Texas MD Anderson Cancer Center - Form 483, 2002-06-14
January, 2005 EIR Janet Lowther, BS, CI - EIR, 2005-01-14
February, 2004 EIR Lifegift Organ Donation Center - EIR, 2004-02-10
February, 2006 FDA 483 Harvey Resnick Md - Form 483, 2006-02-28
February, 2002 EIR Biomat USA, Inc - EIR, 2002-02-12
June, 2002 EIR University of Texas MD Anderson Cancer Center - EIR, 2002-06-14
June, 2002 EIR Biomat USA, Inc - EIR, 2002-06-19
April, 2002 FDA 483 Biomat USA, Inc - Form 483, 2002-04-22
March, 2002 EIR BPL Plasma, Inc. - EIR, 2002-05-02
May, 2002 EIR University of Texas Medical Branch (UTMB) Blood Center - EIR, 2002-05-20
April, 2002 EIR Biomat USA, Inc - EIR, 2002-04-22
March, 2001 FDA 483 Transplantation Research Foundation - Form 483, 2001-03-19
March, 2002 EIR Biomat USA, Inc - EIR, 2002-03-01
March, 2002 FDA 483 BPL Plasma, Inc. - Form 483, 2002-03-06
March, 2003 EIR American Red Cross Blood Services-SW Region - EIR, 2003-03-04
January, 2005 FDA 483 Response Janet Lowther, BS, CI - Form 483R, 2005-01-28
January, 2005 FDA 483 Janet Lowther, BS, CI - Form 483, 2005-01-14
March, 2002 FDA 483 Biomat USA, Inc - Form 483, 2002-03-01
March, 2002 FDA 483 Human Investigations Committee of Houston Texas - Form 483, 2002-03-25
March, 2002 FDA 483 Response BPL Plasma, Inc. - Form 483R, 2002-03-22
November, 2000 EIR Gulf Coast Regional Blood Center - EIR, 2002-03-01

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more